(1) 18–65 years of age, (2) Diagnosed as mild to moderate COVID-19, (3) Be willing to sign informed consent, (4) The clinical assessment and condition of the subject does not influence the completion of the study.

(1) 18–65 years of age, (2) Diagnosed as mild to moderate COVID-19, (3) Be willing to sign informed consent, (4) The clinical assessment and condition of the subject does not influence the completion of the study.